These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9802862)
1. Local delivery of chemotherapy prolongs survival in experimental brain metastases from breast carcinoma. Ewend MG; Sampath P; Williams JA; Tyler BM; Brem H Neurosurgery; 1998 Nov; 43(5):1185-93. PubMed ID: 9802862 [TBL] [Abstract][Full Text] [Related]
2. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models. Ewend MG; Williams JA; Tabassi K; Tyler BM; Babel KM; Anderson RC; Pinn ML; Brat DJ; Brem H Cancer Res; 1996 Nov; 56(22):5217-23. PubMed ID: 8912860 [TBL] [Abstract][Full Text] [Related]
3. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma. Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184 [TBL] [Abstract][Full Text] [Related]
4. O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma. Rhines LD; Sampath P; Dolan ME; Tyler BM; Brem H; Weingart J Cancer Res; 2000 Nov; 60(22):6307-10. PubMed ID: 11103789 [TBL] [Abstract][Full Text] [Related]
5. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model. Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548 [TBL] [Abstract][Full Text] [Related]
6. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors. Sampath P; Hanes J; DiMeco F; Tyler BM; Brat D; Pardoll DM; Brem H Cancer Res; 1999 May; 59(9):2107-14. PubMed ID: 10232596 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas. Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228 [TBL] [Abstract][Full Text] [Related]
8. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma. Yuan X; Tabassi K; Williams JA Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162 [TBL] [Abstract][Full Text] [Related]
9. Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma. Storm PB; Renard VM; Moriarity JL; Tyler B; Wilentz RE; Brem H; Weingart JD Cancer Chemother Pharmacol; 2004 Oct; 54(4):361-7. PubMed ID: 15197484 [TBL] [Abstract][Full Text] [Related]
10. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats. Emerich DF; Winn SR; Bartus RT Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219 [TBL] [Abstract][Full Text] [Related]
11. The role of minocycline in the treatment of intracranial 9L glioma. Weingart JD; Sipos EP; Brem H J Neurosurg; 1995 Apr; 82(4):635-40. PubMed ID: 7897527 [TBL] [Abstract][Full Text] [Related]
12. Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. Brem S; Tyler B; Li K; Pradilla G; Legnani F; Caplan J; Brem H Cancer Chemother Pharmacol; 2007 Oct; 60(5):643-50. PubMed ID: 17256133 [TBL] [Abstract][Full Text] [Related]
13. Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain. Tamargo RJ; Myseros JS; Epstein JI; Yang MB; Chasin M; Brem H Cancer Res; 1993 Jan; 53(2):329-33. PubMed ID: 8417826 [TBL] [Abstract][Full Text] [Related]
14. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. Brem H; Tamargo RJ; Olivi A; Pinn M; Weingart JD; Wharam M; Epstein JI J Neurosurg; 1994 Feb; 80(2):283-90. PubMed ID: 8283268 [TBL] [Abstract][Full Text] [Related]
15. Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma. Frazier JL; Wang PP; Case D; Tyler BM; Pradilla G; Weingart JD; Brem H J Neurooncol; 2003 Sep; 64(3):203-9. PubMed ID: 14558595 [TBL] [Abstract][Full Text] [Related]
16. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma. Yuan X; Dillehay LE; Williams JR; Williams JA Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303 [TBL] [Abstract][Full Text] [Related]
17. Interstitial chemotherapy of experimental brain tumors: comparison of intratumoral injection versus polymeric controlled release. Buahin KG; Brem H J Neurooncol; 1995 Nov; 26(2):103-10. PubMed ID: 8787852 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant treatment with locally delivered OncoGel delays the onset of paresis after surgical resection of experimental spinal column metastasis. Gok B; McGirt MJ; Sciubba DM; Garces-Ambrossi G; Nelson C; Noggle J; Bydon A; Witham TF; Wolinsky JP; Gokaslan ZL Neurosurgery; 2009 Jul; 65(1):193-9; discussion 199-200. PubMed ID: 19574842 [TBL] [Abstract][Full Text] [Related]
19. Interstitial docetaxel (taxotere), carmustine and combined interstitial therapy: a novel treatment for experimental malignant glioma. Sampath P; Rhines LD; DiMeco F; Tyler BM; Park MC; Brem H J Neurooncol; 2006 Oct; 80(1):9-17. PubMed ID: 16636748 [TBL] [Abstract][Full Text] [Related]
20. Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors. Emerich DF; Winn SR; Hu Y; Marsh J; Snodgrass P; LaFreniere D; Wiens T; Hasler BP; Bartus RT Pharm Res; 2000 Jul; 17(7):767-75. PubMed ID: 10990193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]